Skyworks Solutions, Inc. (NASDAQ:SWKS), reported first fiscal quarter results for the period ending January 2, 2015. Revenue for the first fiscal quarter was $805.5 million, up 59 percent year-over-year and 12 percent sequentially, exceeding the Company’s original guidance of $770 million. On Friday shares of Skyworks Solutions Inc. (NASDAQ:SWKS) closed at $80.86. Company’s sales growth for last 5 years was 23.30% and EPS growth for next 5 years is recorded as 19.28%.
On Jan 21, ForgeRock® Inc., the leading open source provider of Identity Relationship Management (IRM) solutions, and FireEye, Inc. (NASDAQ:FEYE) announced an integration of intelligence from the ForgeRock Identity Platform™ with the FireEye® Threat Analytics Platform™ (TAP™) to provide enhanced security incident detection and response management. The integration brings together identity management and security intelligence to deliver a unified dashboard to help security teams identify attacks based on compromised credentials. FireEye, Inc. (NASDAQ:FEYE) in last trading activity moved up 4.14% to close at $34.93. Company weekly performance is 7.61% while its quarterly performance stands at 19.38%. FireEye, Inc. (NASDAQ:FEYE) is -64.12% away from its 52 week high.
TAL International Group (NYSE:TAL) SVP Kevin Valentine sold 2,250 shares of the company’s stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $42.66, for a total value of $95,985.00. On last trading day TAL International Group, Inc. (NYSE:TAL) decreased -1.53% to close at $42.60. Its volatility for the week is 1.98% while volatility for the month is 2.14%. TAL’s sales growth for past 5 years was 8.90% and its EPS growth for past 5 years was 31.30%. TAL International Group, Inc. (NYSE:TAL) monthly performance is 0.16%.
Array BioPharma Inc. (NASDAQ:ARRY) Friday said it has reached a definitive agreement with Novartis Pharma AG to acquire worldwide rights to encorafenib or LGX818, a BRAF inhibitor currently in Phase 3 development. This agreement is conditional on the closing of transactions announced by Novartis and GlaxoSmithKline Plc. on April 22, 2014, which are expected in the first half of 2015. On Friday shares of Array BioPharma, Inc. (NASDAQ:ARRY) closed at $7.11. Company’s sales growth for last 5 years was 11.00% and EPS growth for next 5 years is recorded as 10.00%.
Sony Corp. (ADR) (NYSE:SNE) is delaying the release of its final quarterly earnings, citing the disruption of accounting systems last year during a crippling cyber-attack on the company’s film studio. The Feb. 4 report would include October data for Sony Pictures and forecasts for November and December, a company spokesman said. Sony Corp (ADR) (NYSE:SNE) in last trading activity increased 1.94% to close at $22.60. Company weekly performance is 7.98% while its quarterly performance stands at 28.19%. Sony Corp (ADR) (NYSE:SNE) is 1.25% away from its 52 week high.